Legend Biotech Corporation ( (LEGN) ) has released its Q3 earnings. Here is a breakdown of the information Legend Biotech Corporation presented ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development ... Entyvio, which ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement to acquire Increlex® (mecasermin injection)Q3 2024 produ ...

MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development ... pain relief drugs—Pregabalin and Gabapentin, respectively. Sales of these two approved ...

Engineering sales declined by 15% to €45 million (Fig 2 ... Schott Pharma AG, and West Pharmaceutical Services Inc. After ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, and welcome to the Ampco-Pittsburgh Corporation Third ...

Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...